US 10556881
Nrf2 activating compounds and uses thereof
granted A61PA61P17/06A61P25/00
Quick answer
US patent 10556881 (Nrf2 activating compounds and uses thereof) held by Rigel Pharmaceuticals, Inc. expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P17/06, A61P25/00, A61P29/00, A61P37/00